Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a Neurofibromatosis Clinical Trials Consortium phase II studyBrian Weiss, Michael J. Fisher, Nicole J. Ullrich et al.|Neuro-Oncology|2014Cited by 147
Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromasBrigitte C. Widemann, Frank M. Balis, Eva Dombi et al.|Neuro-Oncology|2014Cited by 114
Sirolimus for non‐progressive NF1‐associated plexiform neurofibromas: An NF clinical trials consortium phase II studyBrian Weiss, Michael J. Fisher, Brigitte C. Widemann et al.|Pediatric Blood & Cancer|2013Cited by 87
Beyond the storm — subacute toxicities and late effects in children receiving CAR T cellsHaneen Shalabi, Nirali N. Shah, Juliane Gust et al.|Nature Reviews Clinical Oncology|2021Cited by 68